Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 65 years or older
- People who are scheduled for hip surgery, either planned (elective) or urgent (emergency), such as surgery to repair a hip fracture or replace a hip joint
- People whose overall health before surgery falls within a low-to-moderate risk range, as assessed by their anaesthetist (known as ASA physical status I–III)
- People who are able to rate their pain on a numbered scale from 0 to 10
- People for whom written consent has been provided — either by the patient themselves or by a legal representative on their behalf
- People for whom the medical team plans to use a specific type of nerve block called a PENG block as part of their pain management around the time of surgery
Who may not be able to join:
- People who are unwilling or unable to give informed consent
- People with a known allergy, intolerance, or medical reason to avoid any of the study medications: ropivacaine, dexamethasone, or dexmedetomidine
- People who already have nerve damage or a neurological condition affecting the leg being treated
- People with blood clotting problems or who are taking blood-thinning medication in a way that makes nerve block procedures unsafe (confirm with trial site)
- People with a skin infection at or near the site where the injection would be given
- People with severely reduced liver or kidney function
- People who have been using opioid pain medicines every day for more than 30 days before their surgery
- People whose thinking or memory difficulties, or current confusion, would make it impossible to reliably report their pain levels
- People with a BMI (a measure of body weight relative to height) above 40 (confirm with trial site)
- People who are already receiving a different type of nerve block for their hip surgery
- People who are pregnant or breastfeeding
- People who have taken part in another interventional clinical trial within the past 30 days
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Malgorzata Reysner, Poznan University of Medical Sciences
Phone: +48 61 873 83 03
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to First Rescue Analgesia
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.